Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy.
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT04929600
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 120 participants
- Registry
-
NCT04929600
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04929600. Randomized; quadruple masking; primary purpose treatment. Start 2021-11-28 (actual); primary completion 2023-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy.
- Condition
- Hypertension
- Condition
- Left Ventricular Hypertrophy
- Intervention (Drug)
- sacubitril/valsartan
- Intervention (Drug)
- Amlodipine
- Lead sponsor
- Shanghai Jiao Tong University School of Medicine
Record details
- Record id
cardio:ct-nct04929600- Content hash
5bf03b1a5ab7b535d87bcbf8e462c076fc7a7455720ae74b8e91d07db2523dff